Prevalence of varicella‐zoster antibodies in pregnant women in Catalonia (Spain). Rationale for varicella vaccination of women of childbearing age

Objective  The objective of this study was to determine the prevalence of antibodies against varicella‐zoster virus (VZV) in pregnant women in Catalonia (Spain).

[1]  Y. Asano.  [A live attenuated varicella vaccine]. , 2009, Uirusu.

[2]  J. Seward,et al.  Prevention of varicella: recommendations of the Advisory Committee on Immunization Practices (ACIP). , 2007, MMWR. Recommendations and reports : Morbidity and mortality weekly report. Recommendations and reports.

[3]  G. Koren.  Congenital varicella syndrome in the third trimester , 2005, The Lancet.

[4]  J. Seward,et al.  Decline in mortality due to varicella after implementation of varicella vaccination in the United States. , 2005, The New England journal of medicine.

[5]  T. Vahlberg,et al.  Seroprevalence, incidence of prenatal infections and reliability of maternal history of varicella zoster virus, cytomegalovirus, herpes simplex virus and parvovirus B19 infection in South‐Western Finland , 2005, BJOG : an international journal of obstetrics and gynaecology.

[6]  S. Knowles,et al.  Susceptibility to infectious rash illness in pregnant women from diverse geographical regions. , 2004, Communicable disease and public health.

[7]  J. Seward,et al.  Varicella Seroprevalence and Molecular Epidemiology of Varicella-Zoster Virus in Argentina, 2002 , 2004, Journal of Clinical Microbiology.

[8]  P. Plans-Rubió.  Critical prevalence of antibodies minimizing vaccination costs for hepatitis A, hepatitis B, varicella, measles and tetanus in adults and adolescents in Catalonia, Spain. , 2004, Vaccine.

[9]  W. Hellenbrand,et al.  Germany adds varicella vaccine to the national vaccination programme , 2004 .

[10]  D. Snashall,et al.  Identification of potential candidates for varicella vaccination by history: questionnaire and seroprevalence study , 2004, British medical journal.

[11]  Isabel Peña-Rey,et al.  Coste-efectividad de la vacunación contra la varicela en adolescentes en España , 2004 .

[12]  J. Seward,et al.  Postpartum Varicella Vaccination: Is the Vaccine Virus Excreted in Breast Milk? , 2003, Obstetrics and gynecology.

[13]  C. Pannuti,et al.  Prevalência de anticorpos para o vírus da varicela-zoster em adultos jovens de diferentes regiões climáticas brasileiras , 2003 .

[14]  B. Sibai,et al.  Frequency of Congenital Varicella Syndrome in a Prospective Cohort of 347 Pregnant Women , 2002, Obstetrics and gynecology.

[15]  B. Sibai,et al.  Risk factors and outcome of varicella-zoster virus pneumonia in pregnant women. , 2002, The Journal of infectious diseases.

[16]  J. Cordero,et al.  Varicella Vaccine Exposure During Pregnancy: Data from the First 5 Years of the Pregnancy Registry , 2001, Obstetrics and gynecology.

[17]  Y. Hutagalung,et al.  Effect of climatic factors and population density on varicella zoster virus epidemiology within a tropical country. , 2001, The American journal of tropical medicine and hygiene.

[18]  S. Garland,et al.  Seroprevalence of varicella zoster virus, parvovirus B19 and Toxoplasma gondii in a Melbourne obstetric population: implications for management , 2001, The Australian & New Zealand journal of obstetrics & gynaecology.

[19]  W. Edmunds,et al.  Modelling the impact of immunization on the epidemiology of varicella zoster virus , 2000, Epidemiology and Infection.

[20]  M. Salleras,et al.  Seroepidemiology of varicella-zoster virus infection in Catalonia (Spain). Rationale for universal vaccination programmes. , 2000, Vaccine.

[21]  N. Nishimura,et al.  Experience with live attenuated varicella vaccine (Oka strain) in healthy Japanese subjects; 10-year survey at pediatric clinic. , 2000, Vaccine.

[22]  B. Mandal,et al.  Adult susceptibility to varicella in the tropics is a rural phenomenon due to the lack of previous exposure. , 1998, The Journal of infectious diseases.

[23]  Lee Bw.  Review of varicella zoster seroepidemiology in India and South‐east Asia , 1998 .

[24]  Lee.  Review of varicella zoster seroepidemiology in India and South‐east Asia , 1998, Tropical medicine & international health : TM & IH.

[25]  T. Koepsell,et al.  Prevention of Chickenpox in Reproductive‐Age Women: Cost‐Effectiveness of Routine Prenatal Screening With Postpartum Vaccination of Susceptibles , 1998, Obstetrics and gynecology.

[26]  T. Stancin,et al.  A long-term prospective study of varicella vaccine in healthy children. , 1997, Pediatrics.

[27]  P. Visintainer,et al.  Seronegativity to Varicella‐Zoster Virus in a Tertiary Care Obstetric Population , 1997, Obstetrics and gynecology.

[28]  T. Vesikari,et al.  Efficacy of high-titer live attenuated varicella vaccine in healthy young children. , 1996, The Journal of infectious diseases.

[29]  R Platt,et al.  The epidemiology of varicella and its complications. , 1995, The Journal of infectious diseases.

[30]  P. Kaye.  Infectious diseases of humans: Dynamics and control , 1993 .

[31]  G. Lenoir,et al.  Measurement of antibodies to varicella-zoster virus in a tropical population by enzyme-linked immunosorbent assay , 1984, Journal of clinical microbiology.

[32]  E. Scolnick,et al.  Live attenuated varicella virus vaccine. Efficacy trial in healthy children. , 1984, The New England journal of medicine.

[33]  G. Fleisher,et al.  Life-threatening complications of varicella. , 1981, American journal of diseases of children.

[34]  A. Nardone,et al.  Varicella zoster virus vaccination policies and surveillance strategies in Europe. , 2005, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.

[35]  A. Nardone,et al.  Varicella zoster virus vaccination policies and surveillance strategies in Europe. , 2005, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.

[36]  P. Wutzler,et al.  [Antibodies against vaccine-preventable diseases in pregnant women and their offspring. Measles, mumps, rubella, poliomyelitis, and varicella]. , 2004, Bundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz.

[37]  P. Reinert,et al.  Varicella vaccine , 2004, Medecine et maladies infectieuses.

[38]  C. Pannuti,et al.  [Prevalence of varicella-zoster virus antibodies in young adults from different Brazilian climatic regions]. , 2003, Revista da Sociedade Brasileira de Medicina Tropical.

[39]  P. Wutzler,et al.  Antikörper gegen impfpräventable Erkrankungen bei Schwangeren und deren Neugeborenen , 2003, Bundesgesundheitsblatt - Gesundheitsforschung - Gesundheitsschutz.

[40]  C. Vandenbroucke-Grauls,et al.  Neonatal antibody titers against varicella-zoster virus in relation to gestational age, birth weight, and maternal titer. , 2002, Pediatrics.

[41]  R. Harpaz,et al.  Prevention of plague: recommendations of the Advisory Committee on Immunization Practices (ACIP). , 1996, MMWR. Recommendations and reports : Morbidity and mortality weekly report. Recommendations and reports.

[42]  G. Demmler,et al.  Rapid enzyme-linked immunosorbent assay for detecting antibody to varicella-zoster virus. , 1988, The Journal of infectious diseases.